TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study
| Image |  |
|---|---|
| Description | scientific article published on 28 July 2017 |
| Author/s |
author: Wataru Okamoto Yasutoshi Kuboki Tomohiro Nishina Toshihiko Doi Shogo Nomura Kentaro Yamazaki Takayuki Yoshino Eiji Shinozaki Kohei Shitara Atsushi Ohtsu |
| Publication date | July 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |